🔎 Trials Near Me

Home › Lupus › New Jersey

Pag-aaral pangklinika para sa Lupus sa New Jersey

6 pag-aaral para sa Lupus ang naghahanap ng mga kalahok sa mga site sa New Jersey.

Mga Lungsod sa New Jersey

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  • Research Site, West Long Branch
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07430306

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  • Rutgers New Jersey Medical School, Newark
  • Arthritis Rheumatic And Back Disease Associates, Voorhees Township
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07438496

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Astera Cancer Care, East Brunswick
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  • Sahni Rheumatology & Therapy, West Long Branch
Nagre-recruitObservasyonal na pag-aaral
Edad 16 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07175285

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

  • Hackensack Meridian Health, Hackensack
Nagre-recruitPhase 3
Edad 55 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05799378

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.